Characterization of the metabolic and physiologic response to chromium supplementation in subjects with type 2 diabetes mellitus - Wikidata - awgldk - TriplyDB

Characterization of the metabolic and physiologic response to chromium supplementation in subjects with type 2 diabetes mellitus

Characterization of the metabolic and physiologic response to chromium supplementation in subjects with type 2 diabetes mellitus

http://www.wikidata.org/entity/Q33609408

about

Molecular mechanisms of chromium in alleviating insulin resistance The effect of chromium picolinate supplementation on the pancreas and macroangiopathy in type II diabetes mellitus rats.Chromium and genomic stability An overview of the identification and management of the metabolic syndrome in chiropractic practice.Chromium Therapy for Insulin Resistance Associated with HIV-Disease Chromium supplementation in non-obese non-diabetic subjects is associated with a decline in insulin sensitivity.Chromium supplementation in overweight and obesity: a systematic review and meta-analysis of randomized clinical trials.Chromium level in prediction of diabetes in pre-diabetic patients.Nutritional supplements for diabetes sold on the internet: business or health promotion?Anti-diabetic potential of chromium histidinate in diabetic retinopathy rats.Systematic review and meta-analysis of the efficacy and safety of chromium supplementation in diabetes.A double-blind, randomized pilot trial of chromium picolinate for binge eating disorder: results of the Binge Eating and Chromium (BEACh) study Dietary chromium supplementation for targeted treatment of diabetes patients with comorbid depression and binge eating.Defining insulin resistance from hyperinsulinemic-euglycemic clamps Risk of Type 2 Diabetes Is Lower in US Adults Taking Chromium-Containing Supplements.Chromium supplements for glycemic control in type 2 diabetes: limited evidence of effectiveness Brewer's Yeast Improves Glycemic Indices in Type 2 Diabetes Mellitus.Metal-based anti-diabetic drugs: advances and challenges.Red carpeting the newer antidiabetics.Selenium, Vanadium, and Chromium as Micronutrients to Improve Metabolic Syndrome.Controlling type-2 diabetes by inclusion of Cr-enriched yeast bread in the daily dietary pattern: a randomized clinical trial.Author reply: Characterization of the metabolic and physiologic response to chromium supplementation in subjects with type 2 diabetes mellitus.Chromium picolinate modulates serotonergic properties and carbohydrate metabolism in a rat model of diabetes.The Potential of Cr3 [Triaqua-μ3 -Oxo-Hexa-μ-Propionatotrichromium(III) Chloride] to Reduce Birth Defects in the Offspring of Diabetic CD-1 Mice.Improved meta-analytic methods show no effect of chromium supplements on fasting glucose.Chromium nicotinate has no effect on insulin sensitivity, glycemic control, and lipid profile in subjects with type 2 diabetes.Profile of Trace Elements in Selected Medicinal Plants Used for the Treatment of Diabetes in Eritrea.

P2860

Q28262068-28F4FFCF-FED2-4B12-96AF-D8574CED9C87 Q33905136-F4E686F7-52AF-4E96-AE9A-07098670CD0C Q34069447-8D7E1E71-B6D3-48D5-B138-C91EE3F95B25 Q34168107-9A2026AE-D576-427C-9CF9-7507B2AE2893 Q34390688-710AB967-CE86-43CD-B615-9BE66C47634B Q34495639-C2CB574E-451D-4618-AEFA-FDC3F12E2B0E Q34621282-F19F7096-C325-499D-9464-A72A4DD80E53 Q34659680-30DC8983-1A4C-4185-A0A6-6715972B9D6A Q34974435-8312582C-55D9-4ACA-9CE5-8FC4AB284C8A Q35063866-56BC6318-917A-42C8-85F4-E45C8731D798 Q35122357-6149B52F-5A59-49E6-9243-302C1745BFB5 Q35174979-5456B594-03DA-4D96-AEDB-AF3F0B422A95 Q35928195-762D9CBC-C874-41F9-8133-121802D587DE Q36047260-C3E8F616-3141-4FCD-B150-98BA86A64406 Q36309809-5338D60F-7B50-4E38-BF61-7CF56089E94F Q37228180-5819C7D1-ECDA-4F94-AF42-949E00132F1F Q37349590-64998321-218D-4942-85B8-F61755E17B18 Q37900507-EEFAB2E1-9B2F-4209-BC32-F8C1760CF15A Q38013105-26ED784F-1690-4B5A-8799-0119D6D79BF0 Q39135929-CC887DF9-A648-45FB-BF7C-88C29A10038E Q39297354-A71B17BA-BBA9-4DBB-A025-5D4629B7FD3C Q42417679-5D0BD8F1-D2A3-489C-9173-1635D1C327E3 Q48605076-2695A7D5-8409-4824-94A7-D8D9E75F4F44 Q50586222-2384838D-0386-4533-9C7B-0AAD51B5FEC7 Q51330632-09FFC9DE-54A7-402B-BE47-3EF833E9FB45 Q51334418-559EBB7E-D5F0-4358-B0EC-9C33A0D350A4 Q53747448-C2FB2D21-EEF6-473D-AE7D-8111AC4AFEA4

P2860

Characterization of the metabolic and physiologic response to chromium supplementation in subjects with type 2 diabetes mellitus

http://www.wikidata.org/entity/Q33609408

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Characterization of the metabo ...... with type 2 diabetes mellitus

@ast

Characterization of the metabo ...... with type 2 diabetes mellitus

@en

type

label

Characterization of the metabo ...... with type 2 diabetes mellitus

@ast

Characterization of the metabo ...... with type 2 diabetes mellitus

@en

prefLabel

Characterization of the metabo ...... with type 2 diabetes mellitus

@ast

Characterization of the metabo ...... with type 2 diabetes mellitus

@en

P1433

Q33609408-D1E0FA0E-1AC4-44E9-A2A6-5B8D640E5153

P1476

Q33609408-56EBCFF2-7C07-4623-83FF-AD3452A01A6C

P2093

Q33609408-1E2F7911-EBC3-43B8-9CB1-D6D58DB00060

Q33609408-6B99D22C-56D1-4ED3-9E9E-5F0D46D71EB3

Q33609408-6B9B9290-3246-4595-A46A-2972E94B0B2D

Q33609408-6DA21B21-97EB-485E-9644-B2580E446DA1

Q33609408-7DEC9D10-6179-40A8-A3FE-8F463ADE3315

Q33609408-8049C12A-86BE-4000-AC6E-000E063A2F96

Q33609408-85A3F22A-EDAB-4FCC-979C-41B81D571916

Q33609408-96BDB9A2-FFB6-4DA7-A4EC-EC66D40579E7

Q33609408-9EFCB951-4DD4-4615-8847-479CBA09C129

Q33609408-A37FC41C-9CB0-41F9-B38E-0CE4AFB1B0D5

P2860

Q33609408-018567D6-DB58-4560-BE26-D055E7793473

Q33609408-0B0664C0-C178-4128-8475-DCB649B2E752

Q33609408-0C7369FF-9BBA-4F95-A404-A4A10948FE2A

Q33609408-104F658F-08B0-4329-BC88-8FAAF337BDB4

Q33609408-196B889E-14E7-43F9-B9C9-F735B301D8EF

Q33609408-1A5F01D6-A0B9-4EC4-8189-D4EE9399AB19

Q33609408-1BF18C25-CC1C-41D3-B34E-A96BFE4BD0E8

Q33609408-1F23A806-C8AA-4E94-BEEB-93130E989F20

Q33609408-2C578B7A-4095-418E-8ACF-C99C420E7B0D

Q33609408-430A0DDD-F411-4376-9CA5-EEE42D613021

P304

Q33609408-E83EBD5C-EBF2-4D4D-BA3E-253C82451512

P31

Q33609408-FB5F4F71-1DB8-42D8-9B20-9E118555BD9A

P356

Q33609408-B49610B4-FB8E-42D1-99AC-C3E3F4A0E24C

P433

Q33609408-83ADE255-873C-4E7C-8563-12AAC7C875D8

P478

Q33609408-CE8C3A91-2F73-4C22-95B9-0FBFF2950DC3

P50

Q33609408-D2A2BE30-AD7D-4B3D-B2BA-7E6F38AB691C

P577

Q33609408-2DD55F35-1C9A-4EA7-84E6-A4EAF09F0559

P5875

Q33609408-6E3D4548-D444-42AE-B9E3-AAC27DB0F885

P698

Q33609408-A6D458FA-BDBB-4A22-96F1-D9882F8BA899

P921

Q33609408-E71E376E-0C8E-4C6F-818C-E997AA8DB8AD

P932

Q33609408-E94E8E72-5419-4B29-8655-1791E127A380

P356

J.METABOL.2009.09.023

P1433

P1476

Characterization of the metabo ...... with type 2 diabetes mellitus

@en

P2093

Bradley Newcomer

http://www.w3.org/2001/XMLSchema#string

Corby K Martin

http://www.w3.org/2001/XMLSchema#string

Jennifer Rood

http://www.w3.org/2001/XMLSchema#string

Jianhua Qin

http://www.w3.org/2001/XMLSchema#string

Julie M Martin

http://www.w3.org/2001/XMLSchema#string

Lilian Levitan

http://www.w3.org/2001/XMLSchema#string

Olga Sereda

http://www.w3.org/2001/XMLSchema#string

Patricia Pinsonat

http://www.w3.org/2001/XMLSchema#string

Richard A Anderson

http://www.w3.org/2001/XMLSchema#string

Xian H Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction

Role of chromium in human health and in diabetes

Effect of chromium supplementation on glucose metabolism and lipids: a systematic review of randomized controlled trials

Chromium picolinate enhances skeletal muscle cellular insulin signaling in vivo in obese, insulin-resistant JCR:LA-cp rats.

Glucose clamp technique: a method for quantifying insulin secretion and resistance.

Chromium treatment has no effect in patients with poorly controlled, insulin-treated type 2 diabetes in an obese Western population: a randomized, double-blind, placebo-controlled trial.

Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes.

Dietary supplement use by American women: challenges in assessing patterns of use, motives and costs.

Can claims, misleading information, and manufacturing issues regarding dietary supplements be improved in the United States?

Antidiabetogenic effects of chromium mitigate hyperinsulinemia-induced cellular insulin resistance via correction of plasma membrane cholesterol imbalance.

P304

755-762

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.METABOL.2009.09.023

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P50

William T. Cefalu

P577

2009-12-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40730116

http://www.w3.org/2001/XMLSchema#string

P698

20022616

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

4020630

http://www.w3.org/2001/XMLSchema#string